Medical Technology Analyst Zimmerman holds meetings with management in Minneapolis on December 9-10 hosted by BTIG.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEN:
- Penumbra price target raised to $240 from $210 at Morgan Stanley
- Penumbra price target raised to $270 from $232 at BTIG
- Penumbra price target raised to $250 from $235 at Piper Sandler
- Penumbra’s CAVT technology shows benefits in pulmonary embolism
- Penumbra price target raised to $232 from $222 at RBC Capital
Questions or Comments about the article? Write to editor@tipranks.com